Skip to main content
Premium Trial:

Request an Annual Quote

Panagene to Supply Dako with PNA Probes

NEW YORK (GenomeWeb News) – South Korean firm Panagene today said that it has signed an agreement to provide Dako with Peptide Nucleic Acid probes for use in diagnostic or research products.

PNA is an artificially synthesized DNA analogue that Panagene said has higher binding affinity, specificity, and sensitivity to a target, as well as high biological/chemical stability. Terms of the agreement were not disclosed.

Dako currently offers a telomere PNA kit for flow cytometry, which measures telomeric sequences in vertebrate interphase hematopoietic cells, a PNA ISH detection kit for performing in situ hybridization, and an Epstein-Barr Virus PNA Probe/Fluorescein product for detecting the two nuclear RNA transcripts EBER1 and EBER2 encoded by Epstein-Barr virus.

Dako is part of Agilent Technologies, following a $2.2 billion acquisition last year.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.